With the US approval of its combination therapy for glaucoma Rocklatan, Aerie Pharmaceuticals Inc. now has two glaucoma eye-drop products on the market and the firm is agnostic as to which product doctors or patients choose in the early going.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?